Rivia

From eligibility screening to endpoint evaluation, balance safety against efficacy with a real-time, patient-level view you can trust.

See enrollment, safety, and protocol adherence across every trial in real time, so you walk into board meetings with answers ready.

Catch cross-form and cross-domain issues that EDC edit checks miss, without programming, and track every finding through to resolution.

Track site and CRO progress against plan in real time, resolve queries before they delay database lock, and keep operations predictable.

How Scancell is succeeding with Rivia.

How Calypso Biotech is succeeding with Rivia.

How Aclaris is succeeding with Rivia.

Biotech sponsors use Rivia’s real-time data to accelerate decisions, adjust dosing, and reduce trial time.

Introducing Data Findings, an AI-powered data review module designed to reduce costly delays in drug development through automated data checks.

Zurich, Switzerland – 10 Oct 2025 – RIVIA, the clinical trial intelligence company, today announced the appointment of Tristan Heintz, PhD as Scientific Expert, reinforcing its commitment to scientific rigor and data-driven innovation in clinical development.

Rivia’s AI-powered data engine unifies fragmented clinical trial data, applies specific scientific logic at scale, and embeds agents directly into high-volume review workflows for operators to reduce trial costs by up to 50%

Help fuel therapeutic innovation through AI and technology, and join the team building the future of clinical trial data.

Rivia provides quarterly plans tailored to trial phases, from first-in-human studies to late-stage endpoints.

Rivia’s team of clinicians and engineers helps biotechs develop therapies faster at lower costs.

Rivia meets ISO 27001, ISO 9001, GDPR, FDA 21 CFR Part 11, and ICH GCP requirements for clinical trial data.

Rivia offers demos, answers questions, and supports clinical trial data needs.

Rivia consolidates trial data from multiple vendors into a unified intelligence layer for real-time insights and operations.

The Terms of Use outline access rules for Rivia’s clinical trial data platform, including service terms and Swiss jurisdiction.